BR112014005011A2 - compound, treatment methods and pharmaceutical composition - Google Patents

compound, treatment methods and pharmaceutical composition

Info

Publication number
BR112014005011A2
BR112014005011A2 BR112014005011A BR112014005011A BR112014005011A2 BR 112014005011 A2 BR112014005011 A2 BR 112014005011A2 BR 112014005011 A BR112014005011 A BR 112014005011A BR 112014005011 A BR112014005011 A BR 112014005011A BR 112014005011 A2 BR112014005011 A2 BR 112014005011A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
treatment methods
treatment
methods
Prior art date
Application number
BR112014005011A
Other languages
Portuguese (pt)
Inventor
Haynes Nancy-Ellen
Robert Scott Nathan
John Silvester Huby Nicholas
Original Assignee
F Hoffamann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffamann-La Roche Ag filed Critical F Hoffamann-La Roche Ag
Publication of BR112014005011A2 publication Critical patent/BR112014005011A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
BR112014005011A 2011-09-01 2012-08-29 compound, treatment methods and pharmaceutical composition BR112014005011A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161529942P 2011-09-01 2011-09-01
PCT/EP2012/066721 WO2013030205A1 (en) 2011-09-01 2012-08-29 Parp inhibitors

Publications (1)

Publication Number Publication Date
BR112014005011A2 true BR112014005011A2 (en) 2017-05-30

Family

ID=46796563

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014005011A BR112014005011A2 (en) 2011-09-01 2012-08-29 compound, treatment methods and pharmaceutical composition

Country Status (9)

Country Link
EP (1) EP2758370A1 (en)
JP (1) JP2014531416A (en)
KR (1) KR20140062096A (en)
CN (1) CN103906730A (en)
BR (1) BR112014005011A2 (en)
CA (1) CA2846429A1 (en)
MX (1) MX2014002343A (en)
RU (1) RU2014110624A (en)
WO (1) WO2013030205A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5441864A (en) * 1977-09-02 1979-04-03 Sankyo Co Ltd Beta-lactam homolog and its preparation
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
WO2007144652A2 (en) * 2006-06-15 2007-12-21 Kudos Pharmaceuticals Limited Parp inhibitors
WO2010139966A1 (en) * 2009-06-05 2010-12-09 Oslo University Hospital Hf Azole derivatives as wtn pathway inhibitors

Also Published As

Publication number Publication date
RU2014110624A (en) 2015-10-10
MX2014002343A (en) 2014-04-30
CN103906730A (en) 2014-07-02
JP2014531416A (en) 2014-11-27
EP2758370A1 (en) 2014-07-30
CA2846429A1 (en) 2013-03-07
KR20140062096A (en) 2014-05-22
WO2013030205A1 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
BR112015002738A2 (en) compound and pharmaceutical composition
BR112014002621A2 (en) antibody, pharmaceutical composition, pharmaceutical combination, DNA and treatment method
BR112013033811A2 (en) composition, method of preparing the composition, and
DK2694038T3 (en) PHARMACEUTICAL COMPOSITION
BR112012022879A2 (en) compound, pharmaceutical composition, compound use and treatment method
BR112014023937A2 (en) pharmaceutical composition, pharmaceutical combination and treatment method
PL2672966T3 (en) Pharmaceutical composition, methods for treating and uses thereof
BR112012022878A2 (en) compound, pharmaceutical composition, compound use and method of treatment
BR112013010725A2 (en) Method and composition
RS61827B1 (en) Pharmaceutical composition, methods for treating and uses thereof
BR112015003259A2 (en) compound, pharmaceutical composition, and vaccine composition.
BR112014004192A2 (en) seed treatment composition and seed treatment method
BR112014010290A2 (en) pharmaceutical composition, methods, compositions and uses
BR112014007203A2 (en) compound, pharmaceutical composition, method of treatment, use of a compound, assembly and invention
BR112013014644A2 (en) pharmaceutical composition and complex
BR112014009889A2 (en) disubstituted compounds, compounds and pharmaceutical composition
ITTO20110641A1 (en) PHARMACEUTICAL COMPOSITIONS AND TREATMENT METHODS
BR112014009950A2 (en) disubstituted compound, compounds and pharmaceutical composition
BR112013019327A2 (en) compound and composition.
BR112013022820A2 (en) treatment method
BR112013022306A2 (en) Method and composition
BR112014003556A2 (en) virus treatment method and pharmaceutical composition
CO6811865A2 (en) Dengue fever treatment method
BR112014012759A2 (en) compound, composition and method for treatment
BR112013019224A2 (en) composition, and method

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired